[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer

Exclusion Criteria

• •• Age \<18 years
• •Presence of tumor spread outside the corpus uteri
• •Absence of tumor invasion into the myometrium
• •High-grade tumor (G3)
• •Bokhman type 2 tumor (e.g., clear cell adenocarcinoma, serous adenocarcinoma, carcinosarcoma, endometrial stromal sarcoma)
• •Preoperative treatment of endometrial cancer including radiotherapy, systemic chemotherapy, or hormone therapy
• •Prior pelvic or retroperitoneal LND
• •History of surgeries on the uterus and uterine appendages, with exceptions such as cesarean section, tubectomy, oophorectomy, ovarian resection, ovarian biopsy, and ovarian cauterization
• •Allergy to iodine-containing drugs
• •Contraindications to surgical treatment
• •Lack of signed informed consent